Microgestin Fe 1.5/30 Kit
Product Images NDC 51862-870

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Microgestin Fe 1.5/30 (NDC 51862-870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagram of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Microgestin Fe 1.5/30. The image shows detailed molecular structures labeled with each compound's name.*

FDA Label Image

2 (Image 02)

A data table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method' displaying percentage of women experiencing unintended pregnancy for various contraceptive methods during the first year of continuous use. Methods include oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, abstinence, withdrawal, and sterilization. The table provides lowest expected and typical failure rates for each method, with some values marked as not available.*

FDA Label Image

3 (Image 03)

A text warning panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with higher risk for women over 35 years old and those who smoke heavily (15 or more cigarettes per day). The text advises that women using oral contraceptives should strongly avoid smoking.*

FDA Label Image

4 (Image 04)

A bar chart showing circulatory disease mortality rates per 100,000 women by age groups (15-24, 25-34, 35-44, 45+) and comparing smoking status and oral contraceptive use. The chart differentiates ever-users and controls for both smokers and non-smokers across the specified age groups.*

FDA Label Image

5 (Image 05)

Table showing the annual number of birth-related or method-related deaths associated with fertility control per 100,000 nonsterile women. Data is categorized by fertility control method (e.g., no method, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, periodic abstinence) and age groups ranging from 15 to 44 years. Deaths are differentiated as birth-related or method-related.*

FDA Label Image

6 (Image 06)

A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years of age and those who smoke heavily (15 or more cigarettes per day). It advises women using oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

Illustration showing instructions for using the Microgestin Fe 1.5/30 pill kit by Mayne Pharma Inc. It explains that the kit contains 21 yellow active pills for weeks 1 to 3 and brown inactive pills for week 4. The diagram indicates the direction to take pills from left to right each week and includes a hand placing a day label sticker for day 1 adherence.*

FDA Label Image

8 (Image 08)

A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with increased risk associated with age and heavy smoking (15 or more cigarettes per day), especially in women over 35 years. It advises women using oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

A warning text panel regarding cigarette smoking and cardiovascular risk associated with oral contraceptive use. It states that the risk increases with age and heavy smoking, particularly in women over 35, and advises women using oral contraceptives not to smoke.*

FDA Label Image

10 (Image 10)

A data table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The table lists methods including no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence across age ranges from 15-19 to 40-44 years.*

FDA Label Image

11 (Image 11)

An instructional diagram for Microgestin Fe 1.5/30 kit illustrating the pill pack layout and usage. It shows 21 yellow active pills arranged for weeks 1 to 3 and 7 brown inactive pills for week 4. The diagram includes instructions on starting the kit, placing day label stickers, and the direction for taking the pills from left to right each week.*

FDA Label Image

12 (Image 12)

FDA Label Image

13 (Image 13)

Packaging label for Microgestin Fe 1.5/30 Kit, containing Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate tablets. The label notes the tablet strengths and counts, with each kit including 6 blister cards of 28 tablets. Labeler is Mayne Pharma Inc., and the product is for prescription use only with storage instructions provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.